LMR Partners LLP Reduces Stock Position in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

LMR Partners LLP trimmed its holdings in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 69.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,000 shares of the company’s stock after selling 22,938 shares during the quarter. LMR Partners LLP’s holdings in Establishment Labs were worth $433,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Hood River Capital Management LLC purchased a new position in shares of Establishment Labs in the 2nd quarter worth approximately $43,000. California State Teachers Retirement System boosted its stake in Establishment Labs by 14.5% during the first quarter. California State Teachers Retirement System now owns 17,096 shares of the company’s stock worth $870,000 after buying an additional 2,167 shares during the period. Swiss National Bank increased its position in Establishment Labs by 13.6% during the first quarter. Swiss National Bank now owns 37,500 shares of the company’s stock valued at $1,909,000 after acquiring an additional 4,500 shares during the last quarter. Nkcfo LLC purchased a new stake in shares of Establishment Labs in the second quarter valued at $227,000. Finally, Kornitzer Capital Management Inc. KS lifted its holdings in shares of Establishment Labs by 2.5% in the 3rd quarter. Kornitzer Capital Management Inc. KS now owns 248,435 shares of the company’s stock worth $10,750,000 after acquiring an additional 6,050 shares during the last quarter. Institutional investors own 72.91% of the company’s stock.

Analyst Upgrades and Downgrades

ESTA has been the topic of several analyst reports. Citigroup upped their price target on shares of Establishment Labs from $45.00 to $50.00 and gave the company a “neutral” rating in a report on Tuesday, October 1st. BTIG Research increased their price target on Establishment Labs from $62.00 to $65.00 and gave the stock a “buy” rating in a report on Monday, October 14th. JPMorgan Chase & Co. cut their price objective on Establishment Labs from $61.00 to $50.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 7th. Finally, Stephens reiterated an “overweight” rating and issued a $68.00 target price on shares of Establishment Labs in a research note on Wednesday, August 7th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $60.60.

Establishment Labs Price Performance

Shares of ESTA stock opened at $37.52 on Wednesday. Establishment Labs Holdings Inc. has a twelve month low of $21.25 and a twelve month high of $60.12. The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94. The stock has a fifty day simple moving average of $43.06 and a two-hundred day simple moving average of $45.46. The stock has a market capitalization of $1.05 billion, a price-to-earnings ratio of -14.52 and a beta of 1.20.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.